- Home
- XERS vs DEC Comparison
XERS vs DEC Comparison
Compare XERS & DEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XERS | DEC |
|---|---|---|
| Founded | 2005 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | XERS | DEC |
|---|---|---|
| Price | $6.19 | $14.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $10.83 | ★ $22.29 |
| AVG Volume (30 Days) | ★ 1.6M | 557.5K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 7.09% |
| EPS Growth | 100.00 | ★ 311.06 |
| EPS | ★ 0.01 | N/A |
| Revenue | $49,590,000.00 | ★ $1,829,142,000.00 |
| Revenue This Year | $34.37 | $26.53 |
| Revenue Next Year | $22.86 | N/A |
| P/E Ratio | $623.50 | ★ N/A |
| Revenue Growth | ★ 142.67 | 141.54 |
| 52 Week Low | $4.30 | $12.33 |
| 52 Week High | $10.08 | $18.90 |
Technical Indicators
Market Signals| Indicator | XERS | DEC |
|---|---|---|
| Relative Strength Index (RSI) | 49.90 | 36.49 |
| Support Level | $5.81 | $13.84 |
| Resistance Level | $6.41 | $14.99 |
| Average True Range (ATR) | 0.31 | 0.53 |
| MACD | -0.02 | -0.14 |
| Stochastic Oscillator | 30.21 | 0.00 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
About DEC Diversified Energy Company plc
Diversified Energy Co engaged in the production, transportation, and marketing of natural gas, NGLs, and oil, managing a diversified portfolio of mature, long-life assets located across the United States. The company derives revenues from the sale of oil, natural gas and natural gas liquids.